name	nAnno	nOverlap	fc	zscore	pvalue	adjp	or	CIl	CIu
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	13	4	19	8.34	4.2e-05	0.0015	27.6	6.15	101
R-HSA-72649	Translation initiation complex formation	58	7	7.46	6.33	3.8e-05	0.0015	8.67	3.27	19.6
R-HSA-72702	Ribosomal scanning and start codon recognition	58	7	7.46	6.33	3.8e-05	0.0015	8.67	3.27	19.6
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	59	7	7.33	6.26	4.3e-05	0.0015	8.5	3.21	19.2
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	111	10	5.57	6.21	1.2e-05	0.0015	6.35	2.9	12.5
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	112	10	5.52	6.17	1.3e-05	0.0015	6.29	2.87	12.4
R-HSA-72613	Eukaryotic Translation Initiation	119	10	5.19	5.9	2.2e-05	0.0015	5.88	2.69	11.5
R-HSA-72737	Cap-dependent Translation Initiation	119	10	5.19	5.9	2.2e-05	0.0015	5.88	2.69	11.5
R-HSA-72689	Formation of a pool of free 40S subunits	101	9	5.51	5.84	3.6e-05	0.0015	6.24	2.71	12.7
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	51	6	7.27	5.76	0.00016	0.0052	8.38	2.88	20.1
R-HSA-6804757	Regulation of TP53 Degradation	36	5	8.58	5.85	0.00026	0.0065	10.1	3.02	26.6
R-HSA-5689880	Ub-specific processing proteases	220	12	3.37	4.56	0.00023	0.0065	3.71	1.84	6.81
R-HSA-199991	Membrane Trafficking	599	22	2.27	4.11	0.00025	0.0065	2.53	1.52	4.01
R-HSA-6806003	Regulation of TP53 Expression and Degradation	37	5	8.35	5.75	3e-04	0.0069	9.76	2.93	25.7
R-HSA-8856828	Clathrin-mediated endocytosis	140	9	3.97	4.54	0.00044	0.0095	4.36	1.92	8.76
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	42	5	7.36	5.29	0.00055	0.01	8.44	2.56	21.9
R-HSA-5653656	Vesicle-mediated transport	631	22	2.15	3.84	0.00051	0.01	2.38	1.44	3.79
R-HSA-8948751	Regulation of PTEN stability and activity	69	6	5.37	4.68	0.00084	0.015	5.97	2.08	14
R-HSA-8863795	Downregulation of ERBB2 signaling	29	4	8.53	5.2	0.0011	0.016	9.95	2.49	29.3
R-HSA-1227986	Signaling by ERBB2	49	5	6.31	4.78	0.0011	0.016	7.09	2.17	18.2
R-HSA-1169408	ISG15 antiviral mechanism	71	6	5.22	4.58	0.00098	0.016	5.79	2.02	13.6
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	71	6	5.22	4.58	0.00098	0.016	5.79	2.02	13.6
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	100	7	4.33	4.29	0.0012	0.016	4.74	1.82	10.4
R-HSA-162909	Host Interactions of HIV factors	128	8	3.86	4.18	0.0011	0.016	4.21	1.75	8.77
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	15	3	12.4	5.65	0.0016	0.019	15.5	2.77	58
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	15	3	12.4	5.65	0.0016	0.019	15.5	2.77	58
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	15	3	12.4	5.65	0.0016	0.019	15.5	2.77	58
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	32	4	7.73	4.89	0.0017	0.019	8.87	2.24	25.8
R-HSA-8848021	Signaling by PTK6	54	5	5.72	4.46	0.0017	0.019	6.37	1.95	16.2
R-HSA-9006927	Signaling by Non-Receptor Tyrosine Kinases	54	5	5.72	4.46	0.0017	0.019	6.37	1.95	16.2
R-HSA-168638	NOD1/2 Signaling Pathway	35	4	7.06	4.61	0.0023	0.024	8.01	2.03	23
R-HSA-392499	Metabolism of proteins	1907	46	1.49	3.06	0.0023	0.024	1.7	1.18	2.43
R-HSA-5675482	Regulation of necroptotic cell death	18	3	10.3	5.06	0.0028	0.028	12.4	2.27	44.3
R-HSA-6804760	Regulation of TP53 Activity through Methylation	19	3	9.76	4.9	0.0033	0.029	11.6	2.14	41.1
R-HSA-5696394	DNA Damage Recognition in GG-NER	38	4	6.51	4.36	0.0032	0.029	7.31	1.86	20.8
R-HSA-192823	Viral mRNA Translation	89	6	4.17	3.85	0.0031	0.029	4.53	1.59	10.5
R-HSA-5688426	Deubiquitination	295	12	2.51	3.39	0.003	0.029	2.7	1.35	4.94
R-HSA-168927	TICAM1, RIP1-mediated IKK complex recruitment 	20	3	9.27	4.75	0.0039	0.03	10.9	2.03	38.2
R-HSA-5213460	RIPK1-mediated regulated necrosis	20	3	9.27	4.75	0.0039	0.03	10.9	2.03	38.2
R-HSA-5218859	Regulated Necrosis	20	3	9.27	4.75	0.0039	0.03	10.9	2.03	38.2
R-HSA-9013507	NOTCH3 Activation and Transmission of Signal to the Nucleus	20	3	9.27	4.75	0.0039	0.03	10.9	2.03	38.2
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	93	6	3.99	3.71	0.0039	0.03	4.32	1.52	9.99
R-HSA-912631	Regulation of signaling by CBL	21	3	8.83	4.61	0.0045	0.033	10.3	1.92	35.8
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	95	6	3.9	3.65	0.0043	0.033	4.22	1.48	9.75
R-HSA-389357	CD28 dependent PI3K/Akt signaling	22	3	8.43	4.47	0.0051	0.036	9.75	1.83	33.6
R-HSA-389513	CTLA4 inhibitory signaling	22	3	8.43	4.47	0.0051	0.036	9.75	1.83	33.6
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	44	4	5.62	3.94	0.0054	0.037	6.21	1.59	17.5
R-HSA-6794362	Protein-protein interactions at synapses	70	5	4.41	3.68	0.0054	0.037	4.79	1.49	12
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	23	3	8.06	4.35	0.0058	0.038	9.27	1.75	31.7
R-HSA-9006925	Intracellular signaling by second messengers	282	11	2.41	3.08	0.0061	0.039	2.57	1.24	4.81
R-HSA-199418	Negative regulation of the PI3K/AKT network	103	6	3.6	3.4	0.0064	0.041	3.87	1.36	8.91
R-HSA-5663205	Infectious disease	326	12	2.28	3	0.0066	0.041	2.43	1.21	4.43
R-HSA-182971	EGFR downregulation	25	3	7.42	4.12	0.0074	0.043	8.42	1.6	28.5
R-HSA-376176	Signaling by ROBO receptors	25	3	7.42	4.12	0.0074	0.043	8.42	1.6	28.5
R-HSA-5223345	Miscellaneous transport and binding events	25	3	7.42	4.12	0.0074	0.043	8.42	1.6	28.5
R-HSA-937041	IKK complex recruitment mediated by RIP1	25	3	7.42	4.12	0.0074	0.043	8.42	1.6	28.5
R-HSA-6807070	PTEN Regulation	140	7	3.09	3.19	0.0076	0.043	3.3	1.28	7.15
R-HSA-6785807	Interleukin-4 and 13 signaling	108	6	3.43	3.26	0.0081	0.045	3.68	1.3	8.46
R-HSA-168255	Influenza Life Cycle	143	7	3.03	3.13	0.0085	0.045	3.23	1.25	6.99
R-HSA-1257604	PIP3 activates AKT signaling	254	10	2.43	2.97	0.0082	0.045	2.59	1.2	4.98
R-HSA-422475	Axon guidance	295	11	2.3	2.92	0.0084	0.045	2.45	1.19	4.58
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	27	3	6.87	3.91	0.0091	0.046	7.72	1.47	25.8
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	51	4	4.85	3.53	0.0091	0.046	5.28	1.36	14.7
R-HSA-75153	Apoptotic execution  phase	51	4	4.85	3.53	0.0091	0.046	5.28	1.36	14.7
R-HSA-8878166	Transcriptional regulation by RUNX2	80	5	3.86	3.3	0.0095	0.046	4.15	1.29	10.3
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	182	8	2.72	3	0.0094	0.046	2.89	1.21	5.96
R-HSA-72766	Translation	258	10	2.4	2.91	0.0091	0.046	2.55	1.18	4.89
R-HSA-6811436	COPI-independent Golgi-to-ER retrograde traffic	52	4	4.75	3.48	0.0098	0.047	5.17	1.34	14.4
R-HSA-69202	Cyclin E associated events during G1/S transition 	82	5	3.77	3.23	0.01	0.047	4.04	1.26	10
R-HSA-5357801	Programmed Cell Death	115	6	3.22	3.08	0.011	0.047	3.44	1.22	7.89
R-HSA-927802	Nonsense-Mediated Decay (NMD)	115	6	3.22	3.08	0.011	0.047	3.44	1.22	7.89
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	115	6	3.22	3.08	0.011	0.047	3.44	1.22	7.89
R-HSA-5358351	Signaling by Hedgehog	148	7	2.92	3.02	0.01	0.047	3.11	1.21	6.73
R-HSA-162906	HIV Infection	184	8	2.69	2.96	0.01	0.047	2.86	1.19	5.89
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	54	4	4.58	3.38	0.011	0.048	4.96	1.29	13.8
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	30	3	6.18	3.64	0.012	0.05	6.86	1.32	22.6
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	30	3	6.18	3.64	0.012	0.05	6.86	1.32	22.6
R-HSA-114604	GPVI-mediated activation cascade	55	4	4.5	3.33	0.012	0.05	4.86	1.26	13.5
R-HSA-3371497	HSP90 chaperone cycle for steroid hormone receptors (SHR)	56	4	4.41	3.29	0.013	0.05	4.77	1.24	13.2
R-HSA-5632684	Hedgehog 'on' state	85	5	3.64	3.13	0.012	0.05	3.89	1.21	9.65
R-HSA-168254	Influenza Infection	154	7	2.81	2.9	0.012	0.05	2.98	1.16	6.44
R-HSA-8868773	rRNA processing in the nucleus and cytosol	191	8	2.59	2.84	0.012	0.05	2.74	1.15	5.66
